财务摘要（报告期）（Corvus Pharmaceuticals Inc）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 每股指标： | ||||||||
| 每股收益EPS基本(元) | -0.56 | -0.43 | -0.31 | -0.17 | -0.89 | -0.68 | -0.36 | -0.18 |
| 每股净资产(元) | 0.79 | 0.90 | 1.01 | 1.05 | 1.21 | 1.39 | 1.73 | 1.93 |
| 每股经营现金净流量(元) | -0.49 | -0.38 | -0.27 | -0.17 | -0.58 | -0.42 | -0.27 | -0.14 |
| 每股现金流量净额(元) | -0.01 | 0.14 | -0.11 | -0.08 | -1.08 | -0.83 | -0.75 | -0.69 |
| 盈利能力： | ||||||||
| 净资产收益率平均(%) | -57.02 | -40.59 | -27.23 | -15.00 | -53.90 | -38.92 | -18.77 | -8.88 |
| 总资产净利率(%) | -47.51 | -33.91 | -22.77 | -12.45 | -46.49 | -33.18 | -16.50 | -7.87 |
| 投入资本回报率ROIC(%) | -61.42 | -46.89 | -27.26 | -15.20 | -81.73 | -61.89 | -30.27 | -14.33 |
| 收益质量： | ||||||||
| 营业利润／利润总额(%) | 86.60 | 87.14 | 84.84 | 83.50 | 78.84 | 85.42 | 86.59 | 89.35 |
| 资本结构： | ||||||||
| 资产负债率(%) | 15.08 | 14.73 | 14.74 | 16.03 | 17.77 | 19.50 | 13.13 | 11.42 |
| 权益乘数 | 1.18 | 1.17 | 1.17 | 1.19 | 1.22 | 1.24 | 1.15 | 1.13 |
| 产权比率 | 0.18 | 0.17 | 0.17 | 0.19 | 0.22 | 0.24 | 0.15 | 0.13 |
| 流动资产／总资产(%) | 61.37 | 63.71 | 65.32 | 61.09 | 63.99 | 63.81 | 63.63 | 63.55 |
| 非流动资产／总资产(%) | 38.63 | 36.29 | 34.68 | 38.91 | 36.01 | 36.19 | 36.37 | 36.45 |
| 流动负债／负债合计(%) | 100.00 | 95.37 | 91.82 | 88.85 | 88.68 | 89.22 | 83.55 | 80.09 |
| 非流动负债／负债合计(%) | - | 4.63 | 8.18 | 11.15 | 11.32 | 10.78 | 16.45 | 19.91 |
| 归属母公司股东的权益／投入资本(%) | 117.46 | 139.11 | 98.21 | 100.67 | 101.88 | 116.00 | 125.48 | 128.49 |
| 偿债能力： | ||||||||
| 流动比率 | 4.07 | 4.53 | 4.82 | 4.29 | 4.06 | 3.67 | 5.80 | 6.95 |
| 速动比率 | 4.07 | 4.53 | 4.82 | 4.29 | 4.06 | 3.67 | 5.80 | 6.95 |
| 货币资金／流动负债(%) | 183.72 | 275.45 | 97.45 | 116.45 | 122.39 | 175.90 | 280.40 | 339.56 |
| 营业利润／流动负债(%) | -340.76 | -243.27 | -155.20 | -79.30 | -302.87 | -192.44 | -142.04 | -80.01 |
| 经营活动产生的现金流量净额／流动负债(%) | -348.45 | -257.13 | -169.69 | -97.84 | -251.33 | -139.33 | -123.54 | -69.34 |
| 归属母公司股东的权益／负债合计(%) | 563.17 | 578.71 | 578.21 | 523.76 | 462.80 | 412.85 | 661.34 | 775.61 |
| 经营活动产生的现金流量净额／负债合计(%) | -348.45 | -245.24 | -155.81 | -86.93 | -222.87 | -124.31 | -103.23 | -55.53 |
| 营业利润／负债合计(%) | -340.76 | -232.01 | -142.51 | -70.46 | -268.58 | -171.69 | -118.68 | -64.08 |
| 成长能力： | ||||||||
| 总资产同比增长率(%) | -33.25 | -35.35 | -37.28 | -42.54 | -37.65 | -32.66 | -15.41 | -7.27 |
| 每股净资产同比增长率(%) | -34.56 | -35.00 | -41.40 | -45.55 | -42.25 | -38.49 | -24.02 | -21.77 |
| 总负债同比增长率(%) | -43.35 | -51.15 | -29.59 | -19.35 | -1.37 | 10.53 | -6.44 | -22.11 |
| 基本每股收益同比增长率(%) | 37.08 | 36.76 | 13.89 | 5.56 | 13.59 | 19.05 | 40.98 | 47.06 |
| 归属母公司股东的权益同比增长率(%) | -31.06 | -31.53 | -38.44 | -45.54 | -42.25 | -38.49 | -16.61 | -4.94 |
| 营业利润同比增长率(%) | 28.12 | 33.99 | 15.46 | 11.32 | 15.70 | 15.47 | 36.65 | 35.44 |
| 股东权益合计同比增长率(%) | -31.06 | -31.53 | -38.44 | -45.54 | -42.25 | -38.49 | -16.61 | -4.94 |
| 营运能力： | ||||||||
| 衍生指标： | ||||||||
| 现金及现金等价物净增加额TTM(元) | -539,000.00 | -4,483,000.00 | -20,819,000.00 | -21,806,000.00 | -50,299,000.00 | -47,707,000.00 | -30,438,000.00 | -13,644,000.00 |
| 利润总额TTM(元) | -27,029,000.00 | -30,192,000.00 | -39,023,000.00 | -40,883,000.00 | -41,307,000.00 | -40,727,000.00 | -36,569,000.00 | -39,958,000.00 |
| 投入资本(元) | 32,933,000.00 | 31,837,000.00 | 50,383,000.00 | 48,543,000.00 | 55,081,000.00 | 55,760,000.00 | 64,064,000.00 | 69,830,000.00 |
| 经营活动产生的现金流量净额TTM(元) | -23,935,000.00 | -26,315,000.00 | -27,810,000.00 | -28,710,000.00 | -27,023,000.00 | -26,332,000.00 | -27,828,000.00 | -34,352,000.00 |
| 归属母公司净利润TTM(元) | -27,029,000.00 | -30,192,000.00 | -39,023,000.00 | -40,883,000.00 | -41,307,000.00 | -40,727,000.00 | -36,569,000.00 | -39,958,000.00 |